Medimaging Integrated Solution Inc. (6796.TW) Stock
Medimaging Integrated Solution Inc.

Company profile
Medimaging Integrated Solution reported revenue of 661.39 million TWD for fiscal year 2025, up 22.7% from fiscal year 2024, and net income of 7.73 million TWD. That is a net profit margin of 1.2% for fiscal year 2025. Our analysis of its filings shows revenue growing from 537.15 million TWD in fiscal year 2023 to 661.39 million TWD in fiscal year 2025, 11.0% a year on average.
What stands out
- The United States brought in 75% of revenue by region in fiscal year 2025, up from 70% in fiscal year 2024; the company is based in Taiwan.
- It spent 145.52 million TWD on research and development in fiscal year 2025, 22.0% of its revenue.
- Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.
Figures from company filings; latest fiscal year ended December 31, 2025.
About Medimaging Integrated Solution Inc.
Medimaging Integrated Solution Inc. engages in the design, manufacture and sale of digital medical imaging diagnostic equipments. It also provides digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes, as well as auxiliary tools. It also offers horus scope products, including optical coherence tomography products, control units, scopes, software, and accessories; computing-based AI screening solutions in diabetic retinopathy, wound care, and medical diagnosis; endoscopy solutions comprising a micro camera module for visualization performance and patient-oriented care; and micro camera modules. The company was founded in 2010 and is headquartered in Hsinchu City, Taiwan.
Leadership
- Chu-Ming Cheng — CEO, Chairman & President
- Shih-Ting Huang — Chief Accounting Officer
- Chih-Lu Hsu — Vice President
- Hui-Yu Ko — Vice President
- Ching Yi Fan — Deputy Director of the Finance & Accounting
How much revenue does Medimaging Integrated Solution make?
Medimaging Integrated Solution reported 661.39 million TWD in revenue for fiscal year 2025, up 22.7% from 538.92 million TWD in fiscal year 2024.
Where does Medimaging Integrated Solution make most of its revenue?
United States: 75% of revenue by region in fiscal year 2025, followed by Taiwan (11%).
What companies are similar to Medimaging Integrated Solution?
Listed companies of a similar size in the same industry (targeted healthcare equipment) include St.Shine Optical Co.,Ltd. (1565.TWO), Icares Medicus, Inc. (6612.TWO), Crystalvue Medical Corporation (6527.TWO), Taiwan Biomaterial Co., Ltd. (6649.TWO).
How has Medimaging Integrated Solution's revenue by region changed?
Share of revenue by region in fiscal years 2024 and 2025: United States, 70% and 75%; Taiwan, 13% and 11%; Other, 14% and 9%; Mainland China, 2% and 4%.
How has Medimaging Integrated Solution's revenue changed over the last 5 fiscal years?
Revenue by fiscal year: FY2021, 485.87 million TWD; FY2022, 502.09 million TWD; FY2023, 537.15 million TWD; FY2024, 538.92 million TWD; FY2025, 661.39 million TWD.
Company Information
Contact & Links
Data as of .
How to cite: DataPorium, “Medimaging Integrated Solution Inc. (6796.TW)”, data as of Dec 31, 2025, https://dataporium.tech/stocks/6796.TW